Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

H-ferritin nanoparticle-mediated antibody delivery across the blood-brain barrier.

Frontiers in aging neuroscience·2026

Same author

INHIBITING THE INHIBITOR: WOULD TARGETING PAI-1 RESULT IN A LOW-DOSE, WELL-TOLERATED TREATMENT OF EMPYEMA?

Biomedical sciences instrumentation·2026

Same author

High-Affinity Nanobody Against the LEDGF PWWP Domain Inhibits Chromatin Binding In Vitro.

Biomolecules·2026

Same author

Phagocytes as plaque catalysts: Human macrophages generate seeding-competent Aβ42 fibrils with cross-seeding activity.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Motivational factors for general practice training and career establishment: A cross-sectional study in Flanders, Belgium.

The European journal of general practice·2026

Same author

In silico design of stable single-domain antibodies with high affinity.

Structure (London, England : 1993)·2026

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

Investigating Retinal Circuits and Molecular Localization by Pre-Embedding Immunoelectron Microscopy

Investigating Retinal Circuits and Molecular Localization by Pre-Embedding Immunoelectron Microscopy

Published on: July 12, 2024

Subtle structural differences between human and mouse PAI-1 reveal the basis for biochemical differences.

Maarten Dewilde¹, Britt Van De Craen, Griet Compernolle

¹Laboratory for Pharmaceutical Biology, Katholieke Universiteit Leuven, Belgium.

Journal of Structural Biology

|March 17, 2010

Summary

This summary is machine-generated.

Structural differences in mouse plasminogen activator inhibitor-1 (PAI-1) compared to human PAI-1 reveal key insights. These findings impact the development of targeted PAI-1 inhibitors for various diseases.

More Related Videos

High Resolution Quantitative Synaptic Proteome Profiling of Mouse Brain Regions After Auditory Discrimination Learning

High Resolution Quantitative Synaptic Proteome Profiling of Mouse Brain Regions After Auditory Discrimination Learning

Published on: December 15, 2016

Intravital Two-Photon Imaging of Touch Sensory Axon Morphology in Mouse Skin

Intravital Two-Photon Imaging of Touch Sensory Axon Morphology in Mouse Skin

Published on: December 30, 2025

Related Experiment Videos

Last Updated: Jun 15, 2026

Investigating Retinal Circuits and Molecular Localization by Pre-Embedding Immunoelectron Microscopy

Investigating Retinal Circuits and Molecular Localization by Pre-Embedding Immunoelectron Microscopy

Published on: July 12, 2024

High Resolution Quantitative Synaptic Proteome Profiling of Mouse Brain Regions After Auditory Discrimination Learning

High Resolution Quantitative Synaptic Proteome Profiling of Mouse Brain Regions After Auditory Discrimination Learning

Published on: December 15, 2016

Intravital Two-Photon Imaging of Touch Sensory Axon Morphology in Mouse Skin

Intravital Two-Photon Imaging of Touch Sensory Axon Morphology in Mouse Skin

Published on: December 30, 2025

Area of Science:

Structural Biology
Biochemistry
Pharmacology

Background:

Plasminogen activator inhibitor-1 (PAI-1), a serine protease inhibitor (serpin), is implicated in cardiovascular diseases and tumor development.
PAI-1 is a potential drug target, with varying inhibitor sensitivity observed across different species.
Lack of non-human PAI-1 structures hinders understanding of species-specific differences.

Purpose of the Study:

To determine the structure of latent mouse PAI-1.
To compare the mouse PAI-1 structure with human PAI-1 structures.
To elucidate the molecular basis for species-specific differences in PAI-1 inhibitor sensitivity.

Main Methods:

X-ray crystallography was used to determine the structure of latent mouse PAI-1.
Comparative structural analysis was performed between mouse and human PAI-1 structures.

Main Results:

The structure of latent mouse PAI-1 was elucidated.
Key structural differences were identified, including variations in alpha-helix A positioning, the gate region, and the reactive center loop.
These structural variations suggest that optimal inhibitor binding sites are ortholog-dependent.

Conclusions:

The determined structure of mouse PAI-1 reveals significant differences compared to human PAI-1.
These findings provide a molecular basis for observed species-specific inhibitor responses.
The results will inform rational drug design strategies for developing effective PAI-1 inhibitors.